High Throughput Genomics (HTG), Inc. has announced the launch of the quantitative Nuclease protection assay (qNPA) 96 Max gene expression assay at the American Association of Cancer Research (AACR) annual meeting. This novel testing configuration enables the measurement of 46 genes in a 96 well Array Plate. The test provides researchers with the ability to analyze a larger number of gene signatures for research and clinical validation work in academic and translational medicine. Based on HTG’s proven qNPA ArrayPlate technology platform, this 96 Max gene expression automated assay allows researchers to investigate a larger set of genes with greater precision than traditional gene expression assays. The technology allows academic researchers to quickly and efficiently measure gene expression levels of mRNA and miRNA in a variety of cell and tissue types including formalin-fixed, paraffin-embedded (FFPE) samples. The technology is ideal for detecting small, yet important changes in gene expression levels which other gene expression platforms cannot reliably detect.